ATS 2024 Final Program

Click on the session title to view the speakers

SUNDAY • MAY 19

29

407 Supplemental Oxygen Reassessment: The Impact of the Choosing Wisely Campaign Recommendations on Clinical Practice 408 Practices in Corticosteroid Dosing for Acute Exacerbations of Idiopathic Pulmonary Fibrosis and Association With In-hospital Mortality 409 Practice Patterns of Non-steroidal Immunosuppressive Agent Use in Patients With Sarcoidosis: 2016-2023 410 Understanding the Facilitators and Barriers to Oxygen Therapy for Individuals With Interstitial Lung Disease 411 Cost Differences Among Patients Diagnosed With Pulmonary Arterial Hypertension Based on Medicare Low-Income Subsidy Eligibility 412 Loss of Productivity Among Commercially Insured Patients Treated for Pulmonary Arterial Hypertension 413 Understanding the Factors Influencing Pulmonary 414 Trends in Donor Cause of Death for Lung Transplants: An Expanded Analysis 415 Post-transplant Outcomes in Lung Transplant Recipients Who Underwent Inpatient Expedited Transplant Evaluation 416 Trends in Cardiovascular Mortality in Patients With Sleep Apnea in the United States From 1999 to 2020 417 8-year Trends in Obesity, Type 2 Diabetes, and Glucagon-like Peptide-1 (GLP-1) Use in Patients With Obstructive Sleep Apnea 418 Re-evaluating Lung Cancer Screening Recommendations: An Analysis of Lung and Bronchus Cancer Incidence by Age Group 419 Financial Toxicity After Hospitalization for Pneumonia From 2017-2019 420 Systemwide Patterns of Service Use, At-risk Patients, and the Hospital Readmissions Reductions Program 421 Lung Function in Active-duty Marines After COVID-19 Infection Hypertension Trials Outcome: A Comprehensive Analysis of Trial Completion and Termination Reasons

422 Adaptations of Health System Infrastructure to Care for Hospitalized COVID Patients After Discharge: A Qualitative Study of Ten U.S. Health Systems 423 Excess Mortality for Non-COVID-19 Conditions in 2020 424 Lung Cancer Screening Completion Rates Demonstrate Disparity Between Patient Populations 425 Implementation of Centralized Support for Community Care Lung Cancer Screening

BEHAVIORAL • CLINICAL RAPID POSTER DISCUSSION SESSION

A22 CRITICAL CARE MEDICINE:

ADVANCING BEHAVIORAL SCIENCES AND HEALTH SERVICES RESEARCH

9:15 a.m. - 11:15 a.m.

San Diego Convention Center Room 28C-E (Upper Level)

Poster Viewing

9:15-10:00

Discussion 10:00-11:15 302 Advantages and Caveats of Using the SpO2/FiO2 Ratio to Identify Hypoxemia 303 Automated Electronic Heath Record Based Identification of ARDS 304 Hospital Variation in the Use of Intravenous Benzodiazepines for Sedation During Early Mechanical Ventilation 305 Hospital Variation in Delivery of Skilled Rehabilitation to Mechanically Ventilated Older Adults With Acute Respiratory Failure 306 Practice Variation and Outcomes in Asthma Exacerbations Among Mechanically Ventilated Patients in Pediatric Intensive Care Units (ICUs) Vs. Adult ICUs 307 Perspectives of Family Decision-Makers Around Prolonged Ventilatory Support 308 Estimating the Probability of a Future Short-term Non-elective, Sepsis or Suspected Infection (SI) Hospitalization Following an ED or a Clinic Visit 309 Demarcating “Time-zero” of Sepsis Onset Among Patients With Hospital-onset Sepsis Using Adult Sepsis Event Criteria

ATS 2024 Conference Program • San Diego, CA